Bionano Genomics Inc BNGO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Bionano Adjourns Special Meeting of Stockholders to October 30, 2024
-
Bionano to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
-
Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress
-
Bionano Announces Presentation of Optical Genome Mapping Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2024 Annual Meeting
-
Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Bionano to Report Second Quarter 2024 Financial Results and Host a Conference Call and Webcast on August 7, 2024
-
Bionano Announces Publication of First Multi-Site Study to Analyze the Utility of OGM in Multiple Myeloma
-
Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Trading Information
- Previous Close Price
- $0.44
- Day Range
- $0.44–0.47
- 52-Week Range
- $0.31–3.01
- Bid/Ask
- $0.45 / $0.46
- Market Cap
- $39.52 Mil
- Volume/Avg
- 1.0 Mil / 1.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.45
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 344
- Website
- https://www.bionano.com
Comparables
Valuation
|
Metric
|
BNGO
|
TIHE
|
AKYA
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 0.40 | — | 6.18 |
Price/Sales | 0.45 | — | 1.47 |
Price/Cash Flow | — | — | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BNGO
|
TIHE
|
AKYA
|
|---|---|---|---|
Quick Ratio | 0.68 | 0.00 | 1.89 |
Current Ratio | 1.63 | 0.00 | 2.73 |
Interest Coverage | −130.67 | — | −5.55 |
Quick Ratio
BNGO
TIHE
AKYA
Profitability
|
Metric
|
BNGO
|
TIHE
|
AKYA
|
|---|---|---|---|
Return on Assets (Normalized) | −58.25% | — | −28.12% |
Return on Equity (Normalized) | −93.80% | — | −97.94% |
Return on Invested Capital (Normalized) | −72.52% | — | −32.87% |
Return on Assets
BNGO
TIHE
AKYA
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Jhscjkvyjn | Wypl | $171.3 Bil | |||
| Becton Dickinson & Co
BDX
| Ncvrmzrdl | Jljvb | $68.9 Bil | |||
| Alcon Inc
ALC
| Fwgynwwv | Dvrjvyq | $48.1 Bil | |||
| ResMed Inc
RMD
| Hxtvjljm | Ghbsmgn | $34.3 Bil | |||
| Coloplast AS ADR
CLPBY
| Hqlslwsbp | Wzcj | $28.7 Bil | |||
| West Pharmaceutical Services Inc
WST
| Msrpgngccp | Syky | $21.5 Bil | |||
| The Cooper Companies Inc
COO
| Pbrjmjfg | Zyhcwys | $21.1 Bil | |||
| Hologic Inc
HOLX
| Gkfdgvvg | Gkjkr | $18.6 Bil | |||
| Baxter International Inc
BAX
| Qwxrwbbsx | Dfrvjc | $18.5 Bil | |||
| Align Technology Inc
ALGN
| Fwcvrvvc | Ybgsqpr | $18.0 Bil |
United States